Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy

Title
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy
Authors
Keywords
Paclitaxel, Rapamycin, Trastuzumab, Immunoliposome, Targeting, Breast cancer
Journal
Publisher
Elsevier BV
Online
2017-03-01
DOI
10.1016/j.ejpb.2017.02.020

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started